Please login to the form below

Not currently logged in
Email:
Password:

UMG acquires Europharma

Will attain the firm’s e-learning programmes

EuropharmaUniversal Medica Group (UMG) has acquired medical training firm Europharma in a bid to “pursue greater ambitions” and complies with the EU’s ‘Horizon 2020’ strategic framework to boost the added value of innovative services.

The group will also take over Europharma’s graphic design and technology efforts for the conception and implementation of e-learning and web products.

Nathalie Cesar, founder of Europharma, said: “I am thrilled and proud that this agreement has come to fruition.

“Within Universal Medica Group, Europharma will now have the resources to pursue its greater ambitions whilst preserving its dedication to innovation and this is due to the group’s [UMG] exceptional medical and technological competences.”

Europharma was founded in 1990 and specialises in strategic consulting, pedagogy, science, health and technology, and the firm has created educational material as well as the management of medical training content and training programmes.

Rafi Mardachti, CEO of UMG, said: “The complementarity of the services and the extent of the skills provide UMG with more expertise, allowing the group to further diversify and energise their innovative potential within the health sector.”

Europharma is the fourth branch of UMG and joins medical affairs branch Universal Medica, innovation and new technologies branch Universal Biotech and health communication agency Cherry for Life Science.

Article by
Gemma Jones

19th May 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics